Literature DB >> 19729201

Gene expression profiling in mice with enforced Gata3 expression reveals putative targets of Gata3 in double positive thymocytes.

Jan Piet van Hamburg1, Marjolein J W de Bruijn, Claudia Ribeiro de Almeida, Gemma M Dingjan, Rudi W Hendriks.   

Abstract

The zinc-finger transcription factors Gata3 and ThPOK have both been implicated in positive selection of double positive (DP) thymocytes towards the CD4 lineage. As in the absence of Gata3, expression of ThPOK is lacking, Gata3 may directly regulate ThPOK expression. As ThPOK failed to promote CD4(+) lineage differentiation of Gata3-deficient cells, ThPOK cannot be the only Gata3 target gene essential for the induction of the CD4(+) lineage program. Therefore, it is conceivable that Gata3 is essential for selected DP T cells to reach the developmental stage at which ThPOK expression is induced. Here, we show that Gata3 overexpression does not affect ThPOK expression levels in DP or CD4(+) thymocytes, providing evidence that Gata3 does not directly regulate ThPOK. To identify additional target genes that clarify Gata3 function at the DP thymocyte stage, we performed gene expression profiling assays in wild-type mice and transgenice mice with enforced expression of Gata3, in the presence or absence of the MHC class II-restricted DO11.10 TCR. We found that Gata3 expression in DP cells undergoing positive selection was associated with downregulation of the V(D)J-recombination machinery genes Rag1, Rag2 and TdT. Moreover, Gata3 overexpression was associated with downregulation of many signaling molecules and the induction of modulators of TCR signaling, including Ctla-4 and thrombospondin 2. Together with our previous finding that Gata3 reduces expression of CD5, a negative regulator of TCR signaling, and upregulates TCR expression, these findings indicate that Gata3 in DP cells mainly functions to (i) terminate TCRalpha gene rearrangement, and (ii) regulate TCR signal intensity or duration in cells undergoing positive selection towards the CD4 lineage.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19729201     DOI: 10.1016/j.molimm.2009.08.004

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  6 in total

Review 1.  Tenuous paths in unexplored territory: From T cell receptor signaling to effector gene expression during thymocyte selection.

Authors:  Lie Wang; Yumei Xiong; Rémy Bosselut
Journal:  Semin Immunol       Date:  2010-10       Impact factor: 11.130

Review 2.  The enigma of CD4-lineage specification.

Authors:  Yumei Xiong; Rémy Bosselut
Journal:  Eur J Immunol       Date:  2011-02-10       Impact factor: 5.532

3.  The BTB-ZF family of transcription factors: key regulators of lineage commitment and effector function development in the immune system.

Authors:  Aimee M Beaulieu; Derek B Sant'Angelo
Journal:  J Immunol       Date:  2011-09-15       Impact factor: 5.422

Review 4.  Regulation of the Ifng locus in the context of T-lineage specification and plasticity.

Authors:  Anand Balasubramani; Ryuta Mukasa; Robin D Hatton; Casey T Weaver
Journal:  Immunol Rev       Date:  2010-11       Impact factor: 12.988

5.  TOX is required for development of the CD4 T cell lineage gene program.

Authors:  Parinaz Aliahmad; Asha Kadavallore; Brian de la Torre; Dietmar Kappes; Jonathan Kaye
Journal:  J Immunol       Date:  2011-10-21       Impact factor: 5.422

6.  Impaired proteasome function activates GATA3 in T cells and upregulates CTLA-4: relevance for Sézary syndrome.

Authors:  Heather M Gibson; Anjali Mishra; Derek V Chan; Timothy S Hake; Pierluigi Porcu; Henry K Wong
Journal:  J Invest Dermatol       Date:  2012-09-06       Impact factor: 8.551

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.